Getting FDA approval of a new plant in India meant Ranbaxy was able to push out enough generic Lipitor in March to take the top spot in production of the drug.
After a four-year stint of being unable to ship drugs from its plants in India to the U.S. and Canada, Ranbaxy Laboratories is returning in a big way.
U.S. manufacturers have made a giant leap forward in protecting against cargo theft.
Though pharmaceutical cargo theft has decreased dramatically in the U.S. the last couple of years, the FDA is displaying concern about the health risks stolen drugs can pose.
Drug shortages brought on by difficulties at Sandoz's Boucherville, Quebec, plant have landed the president of the Novartis subsidiary in the hot seat before a committee of the Canadian House of Commons.
Manufacturing problems and disruptions at Novartis ($NVS) plants in Nebraska and Canada led to shortages that have left an ugly trail of unhappy healthcare providers and consumers.
Eli Lilly CEO John C. Lechleiter says the company has big plans for China, and a significant part of the success it expects there will come from expanding supply chain and distribution.
As the 7th-largest world economy and one that has been growing at break-neck speed, Brazil is becoming a more important market for pharmaceuticals. But getting product delivered in the country can be...
The FDA found problems at three Merck KGaA API and drug manufacturing facilities along a single supply chain in Europe last summer from which ingredients were fed to a plant in Germany. It is unusual...
The size of the pharmaceutical market, the number of drugs in short supply, and the fact that many drugs sold in the U.S. are manufactured abroad all fit into the precise formulation for the...